CordenPharma Completes Acquisition of AmbioPharm to Expand Peptide CDMO Network

CordenPharma has completed the acquisition of U.S.-headquartered peptide contract development and manufacturing organization (CDMO) AmbioPharm, expanding its global peptide manufacturing network with facilities in North... The post CordenPharma Completes Acquisition of AmbioPharm to Expand Peptide CDMO Network appeared first on PharmaSource .